Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation IQWiG. Obinutuzumab – Bewertung gemass Section 35a Abs. 1 Satz 10 SGB V. [Obinutuzumab - assessment according to section 35a (paragraph 1, sentence 10) Social Code Book V (dossier assessment)] Cologne: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). IQWiG-Berichte 252. 2014 Indexing Status Subject indexing assigned by CRD MeSH Antibodies, Monoclonal, Humanized; Antineoplastic Agentss; Leukemia, Lymphocytic, Chronic, B-Cell; Treatment Outcome Country of organisation Germany English summary There is no English language summary available. Address for correspondence IQWiG, Im Mediapark 8, DE-50670 Cologne, GERMANY, Tel: +49 (0) 221 - 35685 - 0, Fax: +49 (0) 221 - 35685 - 1 Email: berichte@iqwig.de AccessionNumber 32015000061 Date abstract record published 20/01/2015 |